Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Healthstream (HSTM) EBITDA Margin (2016 - 2025)

Healthstream (HSTM) has disclosed EBITDA Margin for 16 consecutive years, with 3.02% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 1839.0% to 3.02% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.65% through Dec 2025, up 488.0% year-over-year, with the annual reading at 7.94% for FY2025, 486.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 3.02% at Healthstream, down from 9.89% in the prior quarter.
  • The five-year high for EBITDA Margin was 9.89% in Q3 2025, with the low at 15.37% in Q4 2024.
  • Average EBITDA Margin over 5 years is 2.89%, with a median of 5.25% recorded in 2021.
  • The sharpest move saw EBITDA Margin plummeted -818bps in 2022, then skyrocketed 1839bps in 2025.
  • Over 5 years, EBITDA Margin stood at 0.71% in 2021, then tumbled by -1144bps to 8.9% in 2022, then fell by -25bps to 11.16% in 2023, then crashed by -38bps to 15.37% in 2024, then soared by 120bps to 3.02% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 3.02%, 9.89%, and 7.91% for Q4 2025, Q3 2025, and Q2 2025 respectively.